Cardima Revelation Tx Receives Second Rejection Letter, May Need New Data

Cardima may have to collect additional data on its Revelation Tx cardiac ablation catheter to earn FDA approval for an atrial fibrillation indication, the company acknowledged June 2

More from Archive

More from Medtech Insight